Posts In: Pharmaceuticals

Cabinet gives a nod to DNA Technology (Use and Application) Regulation Bill, 2018

The DNA Technology (Use and Application) Regulation Bill 2018 (“Bill”) has been approved by the Cabinet. The Bill makes it mandatory for DNA laboratories to...

Continue Reading

Ministry of Health and Family Welfare imposes ban on manufacturing of Oxytocin by private manufacturers effective 1.07.2018

July 11, 2018 OPS, Pharmaceuticals, states 0

In a Press Release dated 27th June, 2018, the Ministry of Health and Family Welfare has made the following announcements effective 1st July, 2018: Only public sector will...

Continue Reading

Government invites stakeholder views on its recently rolled out Consultation Paper on rationalizing Trade Margins in Medical Devices

The National Institution for Transforming India (“NITI”), Government of India has released a Consultation Paper on 8th June, 2018 inviting stakeholder views on rationalizing trade margins...

Continue Reading

Medical Health and Family Welfare Services issues Guidelines for the registration of importers, manufacturers, retailers, distributors, dealers of ultrasonography and imaging machines

The Directorate of Medical Health and Family Welfare Services, Jaipur (“Directorate”) has, by a notification dated 20th March, 2018, issued Guidelines for the registration of...

Continue Reading

Retail pharmacies must stock generic drugs in separate shelf/rack, says CDSCO

June 29, 2018 OPS, Pharmaceuticals, states 0

With a view to promote the availability of generic medicines, Central Drugs Standard Control Organisation (“CDSCO”) has instructed Drug Controllers of States and Union Territories...

Continue Reading
Read More
CDSCO partially revises the timings for hearing against banning of 349 fixed dose combinations

CDSCO partially revises the timings for hearing against banning of 349 fixed dose combinations

June 13, 2018 OPS, Pharmaceuticals, states 0

The Central Drugs Standard Control Organization (“CDSCO”) has partially revised the timings for hearing to be given to the petitioners or appellants who have appealed...

Continue Reading
Read More
CDSCO takes steps to prevent illegal manufacturing, sale and distribution of Oxytocin

CDSCO takes steps to prevent illegal manufacturing, sale and distribution of Oxytocin

An Office Memorandum dated 21st May, 2018, has been issued by the Central Drugs Standard Control Organization (“CDSCO”) on special operations to prevent and detect illegal...

Continue Reading
Read More
Clinical Establishments (Central Government) Amendment Rules, 2018 gains effect since 18th May, 2018

Clinical Establishments (Central Government) Amendment Rules, 2018 gains effect since 18th May, 2018

In a pathbreaking move to prescribe minimum standards for Medical Diagnostic Laboratories (or Pathological Laboratories), the Ministry of Health and Welfare has notified the Clinical Establishments (Central...

Continue Reading
Read More
Tamil Nadu Clinical Establishments (Regulation) Amendment Act, 2018 will gain effect from 1st June, 2018

Tamil Nadu Clinical Establishments (Regulation) Amendment Act, 2018 will gain effect from 1st June, 2018

In a recent notification published in the Tamil Nadu Gazette on 23rd May, 2018, we are informed that ‘The Tamil Nadu Clinical Establishments (Regulation) Amendment Act,...

Continue Reading
Read More
CDSCO announces list of Notified Bodies under the Medical Devices Rules, 2017

CDSCO announces list of Notified Bodies under the Medical Devices Rules, 2017

May 9, 2018 OPS, Pharmaceuticals, states 0

The Central Drugs Standard Control Organization (“CDSCO”), in a notice dated 4th May, 2018, has announced the notified bodies registered with it to carry out audit of...

Continue Reading